外体生命支持组织登记国际报告2022年:10万名幸存者
Joseph E Tonna1,2, Philip S Boonstra3, Graeme MacLaren4
1From the Division of Cardiothoracic Surgery, Department of Surgery, University of Utah Health, Salt Lake City, Utah.
ASAIO journal (American Society for Artificial Internal Organs : 1992)
|January 5, 2024
概括
埃尔索登记报告详细介绍了2009年至2022年期间154,568例体外膜氧化 (ECMO) 病例,显示成人ECMO使用量增加,患者群体生存率不同. 这些数据有助于中心比较结果并改进护理策略.
科学领域:
- 心血管科学 心血管科学
- 临界护理医学 临界护理医学
- 儿科医学 儿科医学
背景情况:
- 外体生命支持组织 (ELSO) 注册表是外体膜氧化 (ECMO) 的最大的全球数据库.
- 本报告分析了ECMO计划的特点,护理流程和2009年至2022年的结果.
研究的目的:
- 用ELSO注册表数据描述ECMO中心的特点,护理流程和患者的治疗结果.
- 分析不同年龄组ECMO使用,辅助疗法,并发症和生存率的趋势.
主要方法:
- 分析了2009年至2022年期间提交给ELSO注册表的154,568次ECMO运行的数据.
- 使用描述性统计数据 (计数,百分比,中位数,IQR) 来呈现按年,患者组 (新生儿,儿童,成人) 和支持模式的数据.
- 每1000个ECMO小时报告出现并发症.
主要成果:
- 从2009年到2022年,每个中心的成年ECMO运行显著增加,而新生儿和儿科运行则下降.
- 在COVID-19大流行期间,成年人使用倾斜定位增加了 (2019年为15%,2021年为44%).
- 新生儿呼吸器支 (68.5%) 的存活率最高,成人ECPR (29.5%) 的存活率最低.
结论:
- 该ELSO注册表为中心提供了有价值的数据,用于对结果进行比较,并完善ECMO战略.
- 持续开发注册表对于提高其对患者护理和中心绩效改进的实用性至关重要.
更多相关视频
相关概念视频
01:23International Nursing Organizations I
International Nursing Organization (ICN) is a global union of national nurses' organizations. Individual nurses can be a part of ICN through member organizations. Each member organization strives to ensure quality nursing care, sound health policies, the advancement of nursing knowledge, respect for the profession, and a satisfied and competent nursing workforce.
ICN member organizations work to advance the field of nursing and healthcare via policies, partnerships, lobbying, professional...
ICN member organizations work to advance the field of nursing and healthcare via policies, partnerships, lobbying, professional...
01:28International Nursing Organizations II
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:30Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
01:25Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...